148 related articles for article (PubMed ID: 28039702)
1. Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor.
Salman T; Demir L; Varol U; Akyol M; Oflazoglu U; Yildiz Y; Taskaynatan H; Cengiz H; Guvendi G; Kucukzeybek Y; Alacacioglu A; Tarhan O
J BUON; 2016; 21(6):1419-1424. PubMed ID: 28039702
[TBL] [Abstract][Full Text] [Related]
2. The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy.
Akyol M; Alacacioglu A; Demir L; Kucukzeybek Y; Yildiz Y; Gumus Z; Kara M; Salman T; Varol U; Taskaynatan H; Oflazoglu U; Bayoglu V; Tarhan MO
Cancer Biomark; 2017; 18(4):441-449. PubMed ID: 28106545
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study.
Akyol M; Demir L; Alacacioglu A; Ellidokuz H; Kucukzeybek Y; Yildiz Y; Gumus Z; Bayoglu V; Yildiz I; Salman T; Varol U; Kucukzeybek B; Demir L; Dirican A; Sutcu R; Tarhan MO
Chemotherapy; 2016; 61(2):57-64. PubMed ID: 26571369
[TBL] [Abstract][Full Text] [Related]
4. Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy.
Pedersini R; Amoroso V; Maffezzoni F; Gallo F; Turla A; Monteverdi S; Ardine M; Ravanelli M; Vassalli L; Rodella F; Formenti AM; Dalla Volta A; Simoncini EL; Giustina A; Maroldi R; Berruti A
JAMA Netw Open; 2019 Sep; 2(9):e1911080. PubMed ID: 31560383
[TBL] [Abstract][Full Text] [Related]
5. Does obesity interfere with anastrozole treatment? Positive association between body mass index and anastrozole plasma levels.
Hubalek M; Oberguggenberger A; Beer B; Meraner V; Sztankay M; Oberacher H; Schubert B; Wildt L; Seeber B; Giesinger J; Kemmler G; Holzner B; Sperner-Unterweger B
Clin Breast Cancer; 2014 Aug; 14(4):291-6. PubMed ID: 24468298
[TBL] [Abstract][Full Text] [Related]
6. Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?
Oberguggenberger A; Meraner V; Sztankay M; Beer B; Weigel G; Oberacher H; Kemmler G; Czech T; Holzner B; Wildt L; Sperner-Unterweger B; Daniaux M; Hubalek M
BMC Cancer; 2017 Mar; 17(1):226. PubMed ID: 28351392
[TBL] [Abstract][Full Text] [Related]
7. Obesity and endocrine therapy: host factors and breast cancer outcome.
Goodwin PJ
Breast; 2013 Aug; 22 Suppl 2():S44-7. PubMed ID: 24074791
[TBL] [Abstract][Full Text] [Related]
8. Periodontal Health in Women With Early-Stage Postmenopausal Breast Cancer Newly on Aromatase Inhibitors: A Pilot Study.
Taichman LS; Inglehart MR; Giannobile WV; Braun T; Kolenic G; Van Poznak C
J Periodontol; 2015 Jul; 86(7):906-16. PubMed ID: 25672657
[TBL] [Abstract][Full Text] [Related]
9. Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy.
Santa-Maria CA; Blackford A; Nguyen AT; Skaar TC; Philips S; Oesterreich S; Rae JM; Desta Z; Robarge J; Henry NL; Storniolo AM; Hayes DF; Blumenthal RS; Ouyang P; Post WS; Flockhart DA; Stearns V;
Clin Cancer Res; 2016 Mar; 22(6):1395-402. PubMed ID: 26463708
[TBL] [Abstract][Full Text] [Related]
10. The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.
Montagnani A; Gonnelli S; Cadirni A; Caffarelli C; Del Santo K; Pieropan C; Campagna MS; Montomoli M; Petrioli R; Nuti R
Eur J Intern Med; 2008 Dec; 19(8):592-7. PubMed ID: 19046724
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer.
Jones LW; Haykowsky M; Pituskin EN; Jendzjowsky NG; Tomczak CR; Haennel RG; Mackey JR
Oncologist; 2007 Oct; 12(10):1156-64. PubMed ID: 17962609
[TBL] [Abstract][Full Text] [Related]
12. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
13. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.
Karbek B; Bozkurt NC; Topaloglu O; Aslan MS; Gungunes A; Cakal E; Delibasi T
Minerva Endocrinol; 2014 Jun; 39(2):99-105. PubMed ID: 24736484
[TBL] [Abstract][Full Text] [Related]
14. Adipokines: a novel link between adiposity and carotid plaque vulnerability.
Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD
Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969
[TBL] [Abstract][Full Text] [Related]
15. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
Lønning PE; Haynes BP; Dowsett M
Eur J Cancer; 2014 Apr; 50(6):1055-64. PubMed ID: 24507547
[TBL] [Abstract][Full Text] [Related]
16. A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.
Lintermans A; Van Asten K; Wildiers H; Laenen A; Paridaens R; Weltens C; Verhaeghe J; Vanderschueren D; Smeets A; Van Limbergen E; Leunen K; Christiaens MR; Neven P
Breast Cancer Res Treat; 2014 Jul; 146(1):109-16. PubMed ID: 24816806
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.
Martino G; Catalano A; Agostino RM; Bellone F; Morabito N; Lasco CG; Vicario CM; Schwarz P; Feldt-Rasmussen U
PLoS One; 2020; 15(3):e0230681. PubMed ID: 32214378
[TBL] [Abstract][Full Text] [Related]
18. Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors.
Gibb FW; Dixon JM; Clarke C; Homer NZ; Faqehi AMM; Andrew R; Walker BR
J Clin Endocrinol Metab; 2019 Sep; 104(9):3670-3678. PubMed ID: 30920624
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ramadan fasting on serum concentration of apelin-13 and new obesity indices in healthy adult men.
Celik A; Saricicek E; Saricicek V; Sahin E; Ozdemir G; Bozkurt S; Okumus M; Sucakli MH; Cikim G; Coskun Y; Deniz MS; Dogan E; Kilinc M
Med Sci Monit; 2014 Feb; 20():337-42. PubMed ID: 24576923
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy.
Arpino G; De Angelis C; Buono G; Colao A; Giuliano M; Malgieri S; Cicala S; De Laurentiis M; Accurso A; Crispo A; Limite G; Lauria R; Veneziani BM; Forestieri V; Bruzzese D; De Placido S
Breast Cancer Res Treat; 2015 Nov; 154(1):127-32. PubMed ID: 26424165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
